文献速递核素与放射性配体治疗肿瘤 PET/CT

自动化体素剂量学流程:在177Lu-肽受体放射性核素治疗多SPECT/CT显像患者中的应用

A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy.
PubMed 文献 · J Nucl Med · 2022-04-14

研究构建并测试了一套自动化体素级剂量学流程,除肿瘤分割外,器官分割、配准、剂量率估算和曲线拟合均自动化。使用20例神经内分泌肿瘤患者的4时间点177Lu SPECT/CT数据,CNN分割肾脏Dice值0.91-0.94,平均剂量与手动分割差异仅2%-5%。患者间剂量学结果高度可变,流程处理典型患者约25分钟(手动约2分钟)。

要点

  • CNN自动分割肾脏Dice值0.91-0.94,平均剂量与手动分割差异仅2%-5%。
  • 病灶平均吸收剂量均值3.2 Gy/GBq(范围0.2-10.4),左肾0.49(0.24-1.02),右肾0.54(0.31-1.07),健康肝脏0.51(0.27-1.04)。
  • 分割变异所致平均剂量不确定度器官平均6%(3%-17%),病灶平均10%(3%-37%)。

核心结论

  • 整合快速自动化新工具的流程为剂量学引导的放射性核素治疗临床转化提供了能力。

研究设计与样本

  • 构建并测试一套自动化体素级剂量学流程,除肿瘤分割外自动化关键组件(器官分割、配准、剂量率估算、曲线拟合)。
  • 使用20例神经内分泌肿瘤患者(77个肿瘤)的4时间点177Lu SPECT/CT显像数据,由放射科医师分割。

主要发现

  • CNN定义的肾脏Dice值0.91-0.94,平均剂量与手动分割相比差异仅2%-5%。
  • 基于轮廓强度的配准使对齐视觉上增强,体素级拟合R²值高。
  • 患者间剂量学结果高度可变:病灶平均吸收剂量均值3.2 Gy/GBq(范围0.2-10.4),左肾0.49(0.24-1.02),右肾0.54(0.31-1.07),健康肝脏0.51(0.27-1.04)。
  • 达到假设阈值吸收剂量(肾脏23 Gy、肿瘤100 Gy)所需周期数在患者间高度可变。
  • 分割变异所致平均剂量不确定度器官平均6%(范围3%-17%),病灶平均10%(范围3%-37%)。

关键数值与推荐

  • CNN分割肾脏Dice值0.91-0.94。
  • CNN与手动分割平均剂量差异2%-5%。
  • 病灶平均吸收剂量均值3.2 Gy/GBq(范围0.2-10.4)。
  • 左肾平均吸收剂量均值0.49 Gy/GBq(范围0.24-1.02),右肾0.54(范围0.31-1.07),健康肝脏0.51(范围0.27-1.04)。
  • 分割变异所致平均剂量不确定度:器官平均6%(范围3%-17%),病灶平均10%(范围3%-37%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patient-specific dosimetry in radiopharmaceutical therapy (RPT) is impeded by the lack of tools that are accurate and practical for the clinic. Our aims were to construct and test an integrated voxel-level pipeline that automates key components (organ segmentation, registration, dose-rate estimation, and curve fitting) of the RPT dosimetry process and then to use it to report patient-specific dosimetry in 177Lu-DOTATATE therapy. Methods: An integrated workflow that automates the entire dosimetry process, except tumor segmentation, was constructed. First, convolutional neural networks (CNNs) are used to automatically segment organs on the CT portion of one post-therapy SPECT/CT scan. Second, local contour intensity-based SPECT--SPECT alignment results in volume-of-interest propagation to other time points. Third, dose rate is estimated by explicit Monte Carlo (MC) radiation transport using the fast, Dose Planning Method code. Fourth, the optimal function for dose-rate fitting is automatically selected for each voxel. When reporting mean dose, we apply partial-volume correction, and uncertainty is estimated by an empiric approach of perturbing segmentations. Results: The workflow was used with 4-time-point 177Lu SPECT/CT imaging data from 20 patients with 77 neuroendocrine tumors, segmented by a radiologist. CNN-defined kidneys resulted in high Dice values (0.91-0.94) and only small differences (2%-5%) in mean dose when compared with manual segmentation. Contour intensity-based registration led to visually enhanced alignment, and the voxel-level fitting had high R 2 values. Across patients, dosimetry results were highly variable; for example, the average of the mean absorbed dose (Gy/GBq) was 3.2 (range, 0.2-10.4) for lesions, 0.49 (range, 0.24-1.02) for left kidney, 0.54 (range, 0.31-1.07) for right kidney, and 0.51 (range, 0.27-1.04) for healthy liver. Patient results further demonstrated the high variability in the number of cycles needed to deliver hypothetical threshold absorbed doses of 23 Gy to kidney and 100 Gy to tumor. The uncertainty in mean dose, attributable to variability in segmentation, averaged 6% (range, 3%-17%) for organs and 10% (range, 3%-37%) for lesions. For a typical patient, the time for the entire process was about 25 min (∼2 min manual time) on a desktop computer, including time for CNN organ segmentation, coregistration, MC dosimetry, and voxel curve fitting. Conclusion: A pipeline integrating novel tools that are fast and automated provides the capacity for clinical translation of dosimetry-guided RPT.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dewaraja YK, Mirando DM, Peterson AB, et al. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy. J Nucl Med. 2022. PMID: 35422445. doi:10.2967/jnumed.121.263738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。